Literature DB >> 22669360

Evaluation of sexual function in women at two stages of multiple sclerosis.

Fatih Firdolas1, Tunc Ozan, Rahmi Onur, Serpil Bulut, Irfan Orhan.   

Abstract

PURPOSE: In the present study, we aimed to evaluate the sexual function in patients with multiple sclerosis (MS) who were examined in two subgroups and compare the results to the control group with a validated questionnaire.
METHODS: A total of 23 consecutive female MS patients divided into groups with relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) and 45 healthy control subjects were included into the study. The inclusion criteria were as follows: Definite MS, age between 18 and 60 years and an Expanded Disability Status Scale (EDSS) score of <8. The neurologic impairment, the disability and the independence of the patient, and cognitive performances were measured, and also the effect of MS is evaluated by EDSS.
RESULTS: No statistically significant difference was found between two groups. FSFI scores in both groups were significantly lower than the control group. Domain scores for desire, arousal, orgasm, pain, lubrication and satisfaction measured between RRMS and SPMS patients showed no significant difference. Comparing each domain score for arousal, orgasm and satisfaction revealed significantly lower scores in RRMS and SPMS patients compared to control group.
CONCLUSIONS: In this study, we detected statistically significant decrease in FSFI scores in two groups of MS compared to healthy controls. We could not define a difference in sexual function in different stages of MS in women and a statistically significant negative correlation between EDSS and FSFI scores in the two subgroups of MS.

Entities:  

Mesh:

Year:  2012        PMID: 22669360     DOI: 10.1007/s00345-012-0891-4

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  26 in total

1.  Sexual problems in patients suffering from multiple sclerosis.

Authors:  H G Lilius; E J Valtonen; J Wikström
Journal:  Scand J Soc Med       Date:  1976

2.  Multiple sclerosis and sexuality.

Authors:  Anne Katz
Journal:  Am J Nurs       Date:  2011-07       Impact factor: 2.220

3.  Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups.

Authors:  M Zorzon; R Zivadinov; A Bosco; L M Bragadin; R Moretti; L Bonfigli; P Morassi; L G Iona; G Cazzato
Journal:  Mult Scler       Date:  1999-12       Impact factor: 6.312

4.  Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction.

Authors:  M W Nortvedt; T Riise; K M Myhr; A M Landtblom; A Bakke; H I Nyland
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

5.  Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates.

Authors:  Y Barak; A Achiron; A Elizur; U Gabbay; S Noy; I Sarova-Pinhas
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

6.  Prevalence of sexual dysfunction in new heterosexual attenders at a central London genitourinary medicine clinic in 1998.

Authors:  D Goldmeier; A Judd; K Schroeder
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

7.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

8.  Sexual dysfunction in multiple sclerosis.

Authors:  M L Valleroy; G H Kraft
Journal:  Arch Phys Med Rehabil       Date:  1984-03       Impact factor: 3.966

9.  Sexual dysfunction in female patients with multiple sclerosis.

Authors:  P O Lundberg
Journal:  Int Rehabil Med       Date:  1981

10.  Sexual function in women with advanced multiple sclerosis.

Authors:  B M Hulter; P O Lundberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

View more
  1 in total

Review 1.  The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Nader Salari; Razie Hasheminezhad; Amir Abdolmaleki; Aliakbar Kiaei; Nazanin Razazian; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Neurol Sci       Date:  2022-09-17       Impact factor: 3.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.